Altered glucose-stimulated insulin secretion causes primary hyperinsulinemia in a mouse model of low birth weight associated type 2 diabetes: Role of the glucokinase/hexokinase glucose sensing machinery

被引：0
|
作者：
Jimenez-Chillaron, JC [1 ]
Reamer, CJ [1 ]
Przybyla, R [1 ]
Oge, A [1 ]
机构：
[1] Joslin Diabet Ctr, Boston, MA 02215 USA
来源：
PEDIATRIC RESEARCH | 2003年 / 53卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：7A / 7A
页数：1
相关论文
共 38 条
  • [1] Intrauterine undernutrition alters glucose-stimulated insulin secretion during adult life: Contribution of alterations in glucokinase/hexokinase activity ratio to primary hyperinsulinemia
    Jimenez-Chillaron, J
    Reamer, C
    Przybyla, R
    Oge, A
    Patti, ME
    DIABETES, 2003, 52 : A377 - A377
  • [2] Specific PERK inhibitors enhanced glucose-stimulated insulin secretion in a mouse model of type 2 diabetes
    Kim, Min Joo
    Kim, Mi Na
    Min, Se Hee
    Ham, Dong-Sik
    Kim, Ji-Won
    Yoon, Kun-Ho
    Park, Kyong Soo
    Jung, Hye Seung
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2019, 97 : 87 - 91
  • [3] Insights into the mechanism of impaired glucose-stimulated insulin secretion in type 2 diabetes: Role of pyruvate cycling
    Boucher, A
    Lu, DH
    Telemaque-Potts, S
    Mulder, H
    Sherry, D
    Unger, RH
    Newgard, CB
    DIABETES, 2002, 51 : A1 - A1
  • [4] Insulin resistance causes increased beta-cell mass but defective glucose-stimulated insulin secretion in a murine model of type 2 diabetes
    Asghar, Z
    Yau, D
    Chan, F
    LeRoith, D
    Chan, CB
    Wheeler, MB
    DIABETOLOGIA, 2006, 49 (01) : 90 - 99
  • [5] Insulin resistance causes increased beta-cell mass but defective glucose-stimulated insulin secretion in a murine model of type 2 diabetes
    Z. Asghar
    D. Yau
    F. Chan
    D. LeRoith
    C. B. Chan
    M. B. Wheeler
    Diabetologia, 2006, 49 : 90 - 99
  • [6] Insulin resistance causes increased beta-cell mass but defective glucose-stimulated insulin secretion in a murine model of type 2 diabetes
    Z. Asghar
    D. Yau
    F. Chan
    D. LeRoith
    C. B. Chan
    M. B. Wheeler
    Diabetologia, 2006, 49 (3) : 615 - 615
  • [7] The Role of Endogenous Incretin Secretion as Amplifier of Glucose-Stimulated Insulin Secretion in Healthy Subjects and Patients With Type 2 Diabetes
    Woerle, Hans Juergen
    Carneiro, Lucianno
    Derani, Ayman
    Goeke, Burkhard
    Schirra, Joerg
    DIABETES, 2012, 61 (09) : 2349 - 2358
  • [8] A minimal model of glucose-stimulated insulin secretion process explores factors responsible for the development of type 2 diabetes
    Paul, Abhijit
    Das, Phonindra Nath
    Chatterjee, Samrat
    APPLIED MATHEMATICAL MODELLING, 2022, 108 : 408 - 426
  • [9] Effect of Fimasartan on Glucose-Stimulated Insulin Secretion in Patients with Type 2 Diabetes and Hypertension Compared with Amlodipine
    Yang, Ye Seul
    Roh, Eun
    Ahn, Chang Ho
    Lee, Seo Young
    Kong, Sung Hye
    Bae, Jae Hyun
    Kwak, Soo Heon
    Cho, Young Min
    Park, Kyong Soo
    Jung, Hye Seung
    DIABETES, 2017, 66 : A344 - A344
  • [10] Fimasartan increases glucose-stimulated insulin secretion in patients with type 2 diabetes and hypertension compared with amlodipine
    Yang, Ye Seul
    Lim, Min Hyuk
    Lee, Seong Ok
    Roh, Eun
    Ahn, Chang Ho
    Kwak, Soo Heon
    Cho, Young Min
    Kim, Sungwan
    Mari, Andrea
    Park, Kyong Soo
    Jung, Hye Seung
    DIABETES OBESITY & METABOLISM, 2018, 20 (07): : 1670 - 1677
1234